ProShares UltraShort Nasdaq Biotechnology (BIS) Short Interest Ratio & Short Volume → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free BIS Stock Alerts $20.09 +0.15 (+0.75%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial Media ProShares UltraShort Nasdaq Biotechnology Short Interest DataCurrent Short Volume19,300 sharesPrevious Short Volume7,900 sharesChange Vs. Previous Month+144.30%Dollar Volume Sold Short$339,294.00Short Interest Ratio / Days to Cover0.8Last Record DateMarch 31, 2024Outstanding Shares170,000 sharesPercentage of Shares Shorted11.35%Today's Trading Volume6,627 sharesAverage Trading Volume20,787 sharesToday's Volume Vs. Average32% Short Selling ProShares UltraShort Nasdaq Biotechnology ? Sign up to receive the latest short interest report for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIS Short Interest Over TimeBIS Days to Cover Over TimeBIS Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry ProShares UltraShort Nasdaq Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202419,300 shares $339,294.00 +144.3%N/A0.8 $17.58 3/15/20247,900 shares $143,622.00 -2.5%N/A0.3 $18.18 2/29/20248,100 shares $143,086.50 -35.2%N/A0.4 $17.67 2/15/202412,500 shares $220,125.00 +0.8%N/A0.6 $17.61 1/31/202412,400 shares $223,057.40 -10.1%N/A0.6 $17.99 1/15/202413,800 shares $238,188.00 +14.1%N/A1.5 $17.26 Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 12/31/202312,100 shares $218,647.00 +40.7%N/A2.6 $18.07 12/15/20238,600 shares $169,076.00 -4.4%N/A1.8 $19.66 11/30/20239,000 shares $209,520.00 -8.2%N/A1.9 $23.28 11/15/20239,800 shares $239,120.00 -36.8%N/A1.9 $24.40 10/31/202315,500 shares $398,505.00 +23.0%N/A3.3 $25.71 10/15/202312,600 shares $284,760.00 -21.7%N/A3.6 $22.60 9/30/202316,100 shares $360,801.00 +11.0%N/A5 $22.41 9/15/202314,500 shares $309,285.00 -14.2%N/A4.7 $21.33 8/31/202316,900 shares $349,492.00 +59.4%N/A4.9 $20.68 8/15/202310,600 shares $220,904.00 No ChangeN/A2.9 $20.84 7/31/202310,600 shares $216,346.00 +17.8%N/A2.8 $20.41 7/15/20239,000 shares $186,120.00 -4.3%N/A2.3 $20.68 6/30/20239,400 shares $195,901.64 -2.1%N/A2.1 $20.84 6/15/20239,600 shares $184,608.00 -15.0%N/A1.5 $19.23 5/31/202311,300 shares $235,605.00 -15.7%N/A1.3 $20.85 5/15/202313,400 shares $255,538.00 -1.5%N/A1.2 $19.07 4/30/202313,600 shares $268,192.00 -20.0%N/A1.1 $19.72 4/15/202317,000 shares $329,800.00 -9.6%N/A1.2 $19.40 3/31/202318,800 shares $381,452.00 -42.5%N/A1.2 $20.29 3/15/202332,700 shares $694,875.00 +51.4%N/A1.6 $21.25 2/28/202321,600 shares $449,280.00 +67.4%N/A1.1 $20.80 2/15/202312,900 shares $247,422.00 -22.8%N/A0.6 $19.18 1/31/202316,700 shares $305,443.00 +12.1%N/A0.9 $18.29 1/15/202314,900 shares $271,776.00 -77.5%N/A0.8 $18.24 12/30/202266,300 shares $1.30 million +151.1%N/A3.7 $19.64 12/15/202226,400 shares $497,112.00 -65.1%N/A1.4 $18.83 11/30/202275,600 shares $1.40 million +132.6%N/A4.6 $18.55 11/15/202232,500 shares $625,300.00 -35.6%N/A2.1 $19.24 10/31/202250,500 shares $1.06 million -0.4%N/A3.2 $20.94 10/15/202250,700 shares $1.22 million No ChangeN/A2.2 $24.12 9/30/202246,500 shares $1.18 million -2.5%N/A1.6 $25.27 9/15/202247,700 shares $1.10 million +3.9%N/A1.7 $23.08 8/31/202245,900 shares $1.13 million +73.2%N/A1.5 $24.65 8/15/202226,500 shares $533,180.00 +150.0%N/A0.8 $20.12This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry BIS Short Interest - Frequently Asked Questions What is ProShares UltraShort Nasdaq Biotechnology's current short interest? Short interest is the volume of ProShares UltraShort Nasdaq Biotechnology shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 19,300 shares of BIS short. Learn More on ProShares UltraShort Nasdaq Biotechnology's current short interest. What is a good short interest ratio for ProShares UltraShort Nasdaq Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIS shares currently have a short interest ratio of 1.0. Learn More on ProShares UltraShort Nasdaq Biotechnology's short interest ratio. Is ProShares UltraShort Nasdaq Biotechnology's short interest increasing or decreasing? ProShares UltraShort Nasdaq Biotechnology saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 19,300 shares, an increase of 144.3% from the previous total of 7,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProShares UltraShort Nasdaq Biotechnology's short interest compare to its competitors? Here is how the short interest of companies compare to ProShares UltraShort Nasdaq Biotechnology: JPMorgan Healthcare Leaders ETF (0.08%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), Invesco Nasdaq Biotechnology ETF (0.56%), Principal Healthcare Innovators ETF (0.32%), ProShares Ultra Nasdaq Biotechnology (0.75%), Invesco S&P SmallCap Health Care ETF (0.00%), VanEck Biotech ETF (0.29%), VanEck Pharmaceutical ETF (0.15%), and iShares Biotechnology ETF (15.76%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short ProShares UltraShort Nasdaq Biotechnology stock? Short selling BIS is an investing strategy that aims to generate trading profit from ProShares UltraShort Nasdaq Biotechnology as its price is falling. BIS shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProShares UltraShort Nasdaq Biotechnology? A short squeeze for ProShares UltraShort Nasdaq Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIS, which in turn drives the price of the stock up even further. How often is ProShares UltraShort Nasdaq Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: JPMorgan Healthcare Leaders ETF Short Interest Data First Trust Nasdaq Pharmaceuticals ETF Short Interest Data Invesco Nasdaq Biotechnology ETF Short Interest Data Principal Healthcare Innovators ETF Short Interest Data ProShares Ultra Nasdaq Biotechnology Short Interest Data Invesco S&P SmallCap Health Care ETF Short Interest Data VanEck Biotech ETF Short Interest Data VanEck Pharmaceutical ETF Short Interest Data iShares Biotechnology ETF Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings